News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Biovail Corporation Names Peggy Mulligan CFO
August 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Aug 21 (Reuters) - Biovail Corp, Canada's biggest publicly traded drugmaker, named Peggy Mulligan as its new chief financial officer, replacing Adrian De Saldanha who has held the position on an interim basis.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Business
Navigating Funding Freezes and AI Frontiers
June 20, 2025
·
1 min read
·
Lori Ellis
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
·
2 min read
·
Tristan Manalac
Podcast
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
June 18, 2025
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Biopharma Deal Premiums Paint Picture of Cutthroat Negotiations
June 18, 2025
·
4 min read
·
Annalee Armstrong
